Follow-The-Filings

Security · featured owners

CYRX Cryoport Inc.

Health Care COM PAR $0.001 Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 0.0%
  • $20M
  • 1 add

CYRX (Cryoport Inc.) is held in 1 featured 13F book as of 2026 Q2. First Eagle Investment Management is the largest tracked holder by portfolio weight (0.03%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 0.0% (First Eagle Investment Management) · not free-float ownership

  1. First Eagle Investment Manage... add 0.03%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
First Eagle Investment Management 2026 Q2 0.03% Add +70.7% 1,271,424 $20M history

1 current · options excluded

SEC filings

Recent issuer filings from EDGAR · 12 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.07,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
DEFA14A Filing Doc
10-K Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 19 rows shown

Filed Form Detail Links
4 Period Aug 11, 2026 Filing Doc
4 Period Jun 10, 2026 Filing Doc
4 Period Jun 5, 2026 Filing Doc
4 Period Jun 5, 2026 · 3 forms Filing Doc
4 Period Jun 4, 2026 Filing Doc
4 Period Apr 21, 2026 Filing Doc
4 Period Apr 6, 2026 Filing Doc
4 Period Mar 23, 2026 · 3 forms Filing Doc
4 Period Mar 14, 2026 · 3 forms Filing Doc
4 Period Mar 12, 2026 Filing Doc
4 Period Dec 10, 2025 Filing Doc
4 Period Sep 11, 2025 Filing Doc
4 Period Aug 22, 2025 Filing Doc
4 Period Aug 19, 2025 Filing Doc
4 Period Aug 13, 2025 Filing Doc
4 Period Jul 31, 2025 Filing Doc
4 Period Jul 24, 2025 Filing Doc
4 Period Jul 22, 2025 Filing Doc
4 Period Jul 18, 2025 Filing Doc

Updated 4 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue — $228.38M $176.18M
Gross profit $99.33M $99.63M $83.05M
Gross margin * — 43.6% 47.1%
Net income -$99.59M -$114.76M $78.3M
Net margin * — -50.2% 44.4%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $535.11M $341.57M $476.17M
Total non-current assets * $422.63M $361.92M $288.82M
Total assets $957.74M $703.49M $764.99M
Total current liabilities $45.61M $64.56M $219.02M
Total non-current liabilities * $423.11M $237.03M $43.33M
Total equity $489.02M $401.9M $502.64M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$0.757M -$16.32M -$8.58M
Cash from investing $36.04M $176.82M $250.32M
Cash from financing -$23.8M -$161.53M -$21.07M
Net change in cash $9.75M -$1.06M $205.2M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders